2017
DOI: 10.1093/neuonc/nox168.922
|View full text |Cite
|
Sign up to set email alerts
|

Stem-04. Mechanism of Dysregulation and Efficacy of Pharmacologically Targeting the Apc/C in Glioblastoma

Abstract: INTRODUCTION:Pre-clinical interventions to the CNS require direct cranial administration of drugs for relevant therapeutic concentrations since the efficacy of systemic administration is hindered by the blood-brain barrier (BBB). We used MR-guided Focused Ultrasound (MRgFUS) to deliver primary-patient derived mesenchymal stem cells (hMSCs) for the first time, with sub-millimeter precision, in preselected areas. This method is a revolutionary way to deliver cellular therapy to delicate or inoperable regions obv… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles